Illness severity, advanced age, and chronic liver disease were strong predictors of 30-day mortality among hospitalized patients with CAP.
Achieving sustained virological response after direct-acting antiviral therapy reduces liver-related events among those with decompensated HCV cirrhosis.
Individuals with MetALD vs MASLD have significantly higher risks for liver-related events, liver cancer, and extrahepatic cancers.
People who work against their internal clock over a long period of time increase the risk of fatty liver. The correlations ...
A groundbreaking FDA approval offers the first-ever treatment for ultra-rare Thymidine Kinase 2 Deficiency (TK2d). KYGEVVI, a ...
Objectives Metabolic-associated fatty liver disease (MAFLD) is becoming increasingly prevalent worldwide, however, early ...
Access our live advanced streaming chart for ALT Resources PLC stock, free of charge. This unique "area" or candle chart enables you to clearly notice the movements of this ALT Resources stock within ...
JPMorgan's stock has been fighting to stay above the 50-day moving average, as another close below it could be significant since it would mark the second time in three sessions. The stock fell as much ...
Your liver is one of the most vital organs in your body. It filters toxins, processes nutrients, produces bile, and supports metabolism. Every day, it works hard to neutralize byproducts, drugs, ...
HLB said on the 13th that a phase 3 clinical trial of the combination therapy of rivoceranib and camrelizumab, which is being developed as a liver cancer treatment, confirmed prolonged survival even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback